TERI SWEGINNIS: Open Payments
NPI 1992116446 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 41 payments from 15 companies in 2025. Trend: 2023 $442 · 2024 $309 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 12 | $255 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Lilly USA, LLC | 3 | $62 |
| ABBVIE INC. | 3 | $56 |
| Braeburn Inc. | 2 | $52 |
| Gilead Sciences, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $46 |
| Amgen Inc. | 1 | $38 |
| Renalytix AI, Inc. | 2 | $32 |
Products named: SUBLOCADE, AIRSUPRA, CAPLYTA, MOUNJARO, BRIXADI, ARISTADA, EVENITY, MAVYRET.
Industry payments across AZ — which companies pay providers there.
